ORTEXORTEX News
Tracking VYLR? Get live short interest, options flow, and signals on ORTEX.Sign up free →
VY
Earnings PreviewVYLR

Vylor Trails Peers into November Earnings

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 1 Nov 2026, 04:05

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

VYLR has slipped harder than its closest peers over the past week, falling 2.9% against a median decline of roughly 1.8% for the most correlated names in the group. The stock closed at $72.40 on October 30, extending a one-month retreat of just over 7%.

The relative underperformance is notable given how uncrowded the short side remains. Short interest is a thin position by any measure, with roughly 13.7 million shares short and a days-to-cover of 1.79 based on the most recent FINRA fortnightly reading. Borrow costs have crept higher, up about a third over the past week to 0.55%, but remain firmly in low territory. Availability is extremely loose at nearly 4,900% of short interest, meaning the lending pool is nowhere near stressed. That looseness has widened materially since early October, when availability briefly tightened to around 856% on October 2 before reopening. The short side of the trade is easy and cheap, but there is no evidence of any meaningful crowd building there.

Options positioning has shifted more defensively in the days immediately ahead of the November 4 print. The put/call ratio has held above 1.0 for four consecutive sessions through October 30, reaching as high as 1.05 on October 27, after running well below 0.5 through most of October. That is a sharp change in character for the options market on this name. The 52-week high on the PCR is 1.05, meaning the recent cluster represents the most defensive options posture of the past year, concentrated in the final week before results.

The analyst picture has a bullish tilt, but with one clear dissent. Ten firms initiated coverage in early October, and the majority came in positive: Goldman Sachs and UBS both opened with Buy ratings and targets of $87 and $89 respectively, Morgan Stanley started at Overweight with an $85 target, and Oppenheimer and Mizuho each launched at Outperform. BNP Paribas and Keybanc were the exceptions, with Neutral and Sector Weight calls. The consensus mean target is $82.64, roughly 14% above the current price, though the stock has drifted down since those initiations were published. The $3 billion buyback authorization disclosed on October 22 adds a capital-return angle the Street will weigh against near-term earnings delivery.

The November 4 print will test whether the operational momentum that drew a wave of bullish initiations last month is holding up against what has been a softening price trend and a more cautious options market in the days since.

Stocks in this article

See the live data behind this article on ORTEX.

Open VYLR on ORTEX →

How this article was generated

Generated
1 Nov 2026, 04:30
Data as of
1 Nov 2026, 04:05
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.